Microfluidic Organ-on-a-Chip Devices for Liver Disease Modeling In Vitro

Area of Science:

• Biomedical Engineering
• Cell Biology
• Toxicology

Background:

• High mortality rates from liver diseases necessitate advanced research models.
• Liver diseases often progress silently, requiring early diagnostic and therapeutic interventions.
• Microfluidic organs-on-chip platforms provide novel in vitro systems for liver disease research.

Purpose of the Study:

• To comprehensively review microphysiological platforms for modeling liver diseases in vitro.
• To highlight the potential of organs-on-a-chip in studying liver disease pathophysiology and drug efficacy.
• To provide an overview of techniques, disease models, and challenges in liver-on-a-chip development.

Main Methods:

• Review of existing literature on organs-on-a-chip for liver disease modeling.
• Explanation of cell culture techniques (2D, 3D, spheroid) in microfluidic devices.
• Discussion of specific liver disease models (NAFLD, ALD, hepatitis, drug injury) on-chip.

Main Results:

• Microphysiological platforms enable in vitro study of liver disease mechanisms, including cell signaling.
• These platforms allow for the evaluation of drug efficacy at a cellular metabolic level.
• Various liver diseases can be modeled using different cell culture and microfluidic approaches.

Conclusions:

• Organs-on-a-chip platforms are crucial for advancing the understanding and treatment of liver diseases.
• The review provides insights into current methodologies and future directions for liver disease modeling.
• Addressing design challenges is key to optimizing these advanced in vitro models.